European Union International Standa... NGOs United Nations
Canada Greenland Mexico St. Pierre et Miquelon United States of America
|
Canada
Report Title: |
Best Practices Guide to Synthetic Nanoparticle Risk Management |
Report ID: |
570 |
Date: |
1/1/2009 |
Author: |
IRSST |
Report Type: |
Guidance Document |
URL: |
[R-599.pdf] |
Country: |
Canada |
Organization: |
IRSST |
Summary: |
This guide, prepared jointly by the IRSST, CSST, and NanoQuebec, proposes a prevention strategy for workplace and research exposure to nanomaterials. It describes the current health risks and safety risks of nanoparticles, including catalytic reactions and fires, and proposes a structured approach to risk management. A case by case risk assessment is preferred, beginning with preliminary information gathering, then information gathering on both health and safety risks, then detailed information gathering, then risk assessment. After both health and safety risks have been assessed, the proposed structure aims to control these risk factors. These include both quantitative assessment of the accident risk involved and where there is insufficient data for quantitative assessment, qualitative assessment under a “control banding” approach. These steps and protective measures to take when a hazard is assessed to exist are described in detail. |
Archived Copy: |
R-599_570_3102.pdf |
|
|
Report Title: |
Proposed Regulatory Framework for Nanomaterials Under the Canadian Environmental Protection Act of 1990 |
Report ID: |
92 |
Date: |
9/10/2007 |
Report Type: |
Guidance Document |
Country: |
Canada |
Organization: |
Environment Canada / Health Canada |
Summary: |
Environment Canada and Health Canada have developed a proposal for a regulatory framework for nanomaterials under the Canadian Environmental Protection Act, 1999. This document provides background information on nanomaterials and the Canadian Environmental Protection Act, 1999 as well as information on the proposal for developing an effective regulatory framework for nanomaterials. Within the following sections are a brief overview of the science and impacts of nanomaterials,?the role of the New Substances Program in conducting risk assessments, the proposed approach for a regulatory framework for nanomaterials under the Canadian Environmental Protection Act, options for information gathering initiatives, and path forward for Government and private stakeholders. |
|
|
Report Title: |
Small is Different: A Science Perspective on the Regulatory Challenges of the Nanoscale |
Report ID: |
91 |
Date: |
7/1/2008 |
Report Type: |
Guidance Document |
URL: |
[JulyCanadaReport.pdf] |
Country: |
Canada |
Organization: |
Council of Canadian Academies |
Summary: |
This report summarizes the findings of the Expert Panel on Nanotechnology (the panel) established by the Council of Canadian Academies to assess “…the state of knowledge with respect to existing nanomaterial properties and their health and environmental risks, which could underpin regulatory perspectives on needs for research, risk assessment and surveillance.” Given the current limited state of scientific knowledge regarding many nanomaterials, the panel identifies the need to give priority to the development and resourcing of a strategic research agenda to improve our understanding of the risks associated with each specific class of nanomaterials. Research into metrology, into properties of nanomaterials that are linked to biological responses, and into effective monitoring and surveillance strategies should be given high priority as a means of assessing health and environmental risks. Although the panel believes that it is not necessary to create new regulatory mechanisms to address the unique challenges presented by nanomaterials, existing regulatory mechanisms could and should be strengthened. This includes more attention to addressing issues of classification, regulatory triggers and regulatory capacity, and that regulatory agencies coordinate their activities with each other, between federal and provincial levels of government and with the regulatory agencies of other countries. Moreover, a critical aspect of this management in a regulatory context is the involvement of the public, which includes not only self-identified stakeholders but the broader public who act as citizens and consumer advocates. |
|
|
|